Dr Miele Cosmed Group (WAR:DMG) EBIT: zł24.8 Mil (TTM As of Mar. 2026)


WAR:DMG Dr Miele Cosmed Group SA WAR:DMG
70 GF Score
Price zł2.31
GF Value zł3.84
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Dr Miele Cosmed Group EBIT?

Dr Miele Cosmed Group WAR:DMG 70 EBIT is zł24.8 Mil as of Mar. 2026. GuruFocus rates WAR:DMG with a GF Score™ of 70/100 and a GF Value™ of zł3.84 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Dr Miele Cosmed Group's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was zł5.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was zł24.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Dr Miele Cosmed Group's annualized ROC % for the quarter that ended in Mar. 2026 was 4.66%. Dr Miele Cosmed Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 10.32%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Dr Miele Cosmed Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 9.59%.


Dr Miele Cosmed Group  (WAR:DMG) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Dr Miele Cosmed Group's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=19.36 * ( 1 - 12.21% )/( (364.741 + 364.241)/ 2 )
=16.996144/364.491
=4.66 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=425.827 - 64.721 - ( 11.664 - max(0, 127.313 - 123.678+11.664))
=364.741

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Dr Miele Cosmed Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=22.06/( ( (171.791 + max(32.631, 0)) + (174.304 + max(48.842, 0)) )/ 2 )
=22.06/( ( 204.422 + 223.146 )/ 2 )
=22.06/213.784
=10.32 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(45.697 + 57.456 + 3.708) - (64.721 + 0 + 9.509)
=32.631

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(58.232 + 63.193 + 10.554) - (79.169 + 0 + 3.968)
=48.842

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Dr Miele Cosmed Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=24.818/258.876
=9.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Miele Cosmed Group EBIT Related Terms


Dr Miele Cosmed Group EBIT Historical Data

* Premium members only.

The historical data trend for Dr Miele Cosmed Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Miele Cosmed Group EBIT Chart

Dr Miele Cosmed Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.78 1.62 31.89 48.48 29.80

Dr Miele Cosmed Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.50 7.21 8.10 3.99 5.52

WAR:DMG vs PG, CL, KVUE: EBIT Comparison

For the Household & Personal Products subindustry, Dr Miele Cosmed Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Miele Cosmed Group EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Miele Cosmed Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dr Miele Cosmed Group's EV-to-EBIT falls into.


WAR:DMG
70GF Score
Dr Miele Cosmed Group SA WAR:DMG
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Miele Cosmed Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł24.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of zł24.8 Mil mean?
Dr Miele Cosmed Group (WAR:DMG) has a EBIT of zł24.8 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Dr Miele Cosmed Group.
Is Dr Miele Cosmed Group's EBIT too high?
Dr Miele Cosmed Group's current EBIT is zł24.8 Mil. Overall, Dr Miele Cosmed Group has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Miele Cosmed Group's EBIT compare to PG and CL?
Dr Miele Cosmed Group's EBIT of zł24.8 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Dr Miele Cosmed Group. Dr Miele Cosmed Group's current EBIT is zł24.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Miele Cosmed Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Miele Cosmed Group (WAR:DMG) is currently considered Significantly Undervalued. The stock's GF Value™ is zł3.84, compared to a current price of zł2.31 — trading 39.8% below its estimated fair value. The current EBIT is zł24.8 Mil. Dr Miele Cosmed Group's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Dr Miele Cosmed Group (WAR:DMG), the current EBIT is zł24.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Miele Cosmed Group (WAR:DMG) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Miele Cosmed Group stock appears to be undervalued. The current stock price of zł2.31 is trading 39.8% below its estimated GF Value™ of zł3.84. GuruFocus considers Dr Miele Cosmed Group to be Significantly Undervalued.

Key valuation signals for WAR:DMG:

  • EBIT: zł24.8 Mil
  • GF Value™: zł3.84 vs. price of zł2.31 (39.8% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the WAR:DMG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr Miele Cosmed Group Business Description

Address Ulica Wielkopolska 3, Radom, POL, 26-600
Dr Miele Cosmed Group SA is engaged in manufacturing cosmetics and household chemicals for national and international retailers, fulfils consumer needs in the sector of personal care, hygiene and cleanliness. The company's brands include Apart, Biophen, Mole, Bobini, Sofin and Izo.
70GF Score

Get the complete analysis for WAR:DMG

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł2.31
Price
zł3.84
GF Value